---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-072792"
form_type: "8-K"
ticker: "HOOK"
cik: "0001760542"
company_name: "HOOKIPA Pharma Inc."
filed_at: "2024-06-18T23:59:59+00:00"
generated_at: "2026-06-01T03:56:20.077937+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# HOOKIPA shareholders approve doubling authorized shares and authorize reverse split

## Summary
- Authorized common stock increased from 200M to 400M shares; approved by 64.8M for, 3.4M against.
- Shareholders authorized board to implement reverse stock split (1:2 to 1:10) before June 17, 2025; 63.4M for, 4.7M against.
- Directors Timothy Reilly and Malte Peters elected to Class II with 51.9M and 53.9M votes respectively.
- Ratification of PwC Wirtschaftsprüfung GmbH as independent auditor for FY2024 approved (67.6M for).

## SEC filing metadata
- accession: 0001104659-24-072792
- form_type: 8-K
- ticker: HOOK
- cik: 0001760542
- company_name: HOOKIPA Pharma Inc.
- filed_at: 2024-06-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760542/000110465924072792/0001104659-24-072792-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760542/000110465924072792/tm2417487d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-072792
- JSON: https://secwatch.observer/filing/0001104659-24-072792.json
- Plain text: https://secwatch.observer/filing/0001104659-24-072792.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.